The National Institute on Aging (NIA) awarded a $10,774,322 Project Grant (CFDA 93.866 - Aging Research) to The Trustees of Columbia University in the City of New York to conduct the "Multi-Morbidity 3-City Alzheimer's Disease EHR Study (M3AD Study)". The goal of this 1-year study is to leverage large longitudinal electronic health record (EHR) datasets from three diverse urban medical centers to better understand how the trajectory of multimorbidities (timing, order, management)...
The National Institute on Aging (NIA) awarded a $596,258 Project Grant (CFDA 93.866 - Aging Research) to Weill Medical College of Cornell University to characterize and predict patient trajectories after live discharge from hospice among older adults with Alzheimer's disease and related dementias (ADRD). The project aims to apply longitudinal clustering methods to Medicare claims and encounter data to identify patient subgroups with heterogeneous trajectories after hospice live discharge,...
This $121,209 National Institute on Aging project grant will support research assessing the impact of primary care structural capabilities on hospitalizations among older adults with dementia. Specifically, the grantee will analyze cross-sectional data from 2018-2019 to describe structural capabilities like care coordination, electronic health records, and community integration in primary care practices employing nurse practitioners to serve Medicare beneficiaries with Alzheimer's disease and...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to provide an evidence base for improving care coordination and health outcomes among older adults with Alzheimer's disease and related dementias (AD/ADRD) who are dually eligible for Medicare and Medicaid. The $3,548,906 grant, awarded on August 1, 2024 and running through April 30, 2027, will use nationwide linked Medicare-Medicaid administrative data to...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
The National Institute on Aging (NIA) awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $661,016 to the University of Southern California (USC) to develop a "Federated Deep Learning to Accelerate Alzheimer's Disease Research" project. The key products and services to be delivered include: Establishing an international "Federate AD" alliance to leverage innovative AI techniques and distributed computation to study Alzheimer's disease (AD) across large,...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
This federal Project Grant award of $2,763,221 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The 5-year project conducted by Cedars-Sinai Medical Center in West Hollywood, CA will: Determine the effect of physician factors...
This $1,588,040 Project Grant awarded by the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866) will support a study conducted by Wake Forest University Health Sciences to examine the use of home-based medical care (HBMC) and telemedicine among people living with Alzheimer's disease and related dementias (PLWD). The study aims to identify national trends in HBMC and telemedicine use for PLWD under both public (fee-for-service Medicare) and private...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $608,731 to Brown University to conduct research on the impact of Medicare and Medicaid financial policies on post-acute and long-term care for persons living with dementia. The project will leverage 15 years of Medicare claims and clinical assessment data to examine how changes in healthcare financing have affected long-term care utilization and health outcomes for the 6.7 million...
The National Institute on Aging (NIA) awarded a $3,374,303 Project Grant (CFDA 93.866) to Weill Medical College of Cornell University to conduct the "Understanding Ambulatory Care Utilization in Alzheimer's Disease and Related Dementias (ACUA)" study. The 5-year project, starting on Sep 15, 2024, aims to investigate the role of fragmented ambulatory care in the diagnosis and management of people living with dementia, including potential links to disparities in care.
The project involves secondary analyses of NIA-funded cohort studies and national Medicare claims data to examine associations between fragmented care, delayed dementia diagnoses, medication prescribing patterns, and healthcare utilization. Additionally, it includes semi-structured interviews with stakeholders to gather their perspectives on addressing fragmented care for people with dementia. The project will generate insights to inform future interventions for improving ambulatory care and outcomes for this population. Key sub-awardees include the University of Michigan, NewYork Quality Care, and Columbia University, which will provide specialized expertise and data access to support the research activities.